Elena Esperanza Cebollada

Elena Esperanza Cebollada

Investigador post-doc

Researcher Elena Esperanza graduated in Biology at the Autonomous University of Barcelona (UAB) in 2015. During the last year she interned at the Faculty of Biosciences of the UAB studying the methylation of the BIK gene in patients affected by a GMSI and genetic alterations in acute lymphoblastic leukemia, where he became familiar with laboratory work and molecular techniques. Later, during the 2015-2016 academic year, he completed a master's degree in Biological Anthropology with a specialization in human diversity and biomedical applications taught at the UAB and the University of Barcelona (UB). During that year he did the final master's thesis "Next generation sequencing versus high sensitivity flow cytometry for minimal residual disease ALL detection" at the Josep Carreras Leukemia Research Institute (Germans Trias i Pujol Hospital). This project allowed him to be trained in new molecular techniques such as Next Generation Sequencing.

He is currently completing his doctoral dissertation at the Sant Joan de Déu Hospital in the hematology laboratory integrated into the Developmental Tumors research group of the Sant Joan de Déu Barcelona Research Institute. In her research project she studies the epigenetic regulators (HDAC and miRNA) in a number of patients with pediatric acute leukemia. In addition, I complete my training by attending courses and congresses and is part of the European Haematology Association (EHA).

elena.esperanza@sjd.es

Professional network profiles

Related websites

Last Publications

More Publications

Projects

Project name:
SGR 2022-2024_Grup de recerca en tumors del desenvolupament
Leader
Jaume Mora Graupera
Funding entities:
Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
Code
2021 SGR 01612
Starting - finishing date:
2022 - 2025
Project name:
Análisis de los factores pronósticos de fracaso del tratamiento tras terapia con células T con receptores antigénicos quiméricos (CAR-T) en pacientes pediátricos con leucemia linfoblástica aguda de línea B
Leader
Susana Rives Solà, Montserrat Torrebadell Burriel
Funding entities:
Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
Code
PI21/00218
Starting - finishing date:
2022 - 2024
Project name:
Nuevas técnicas para la caracterización molecular completa y la mejora del seguimiento de la enfermedad mínima residual en leucemia aguda pediátrica
Leader
Mireia Camós Guijosa, Nerea Vega García
Funding entities:
Instituto de Salud Carlos III (ISCIII)
Code
PI21/00213
Starting - finishing date:
2022 - 2024
More projects

More activities

More activities